0001209191-17-047016.txt : 20170802 0001209191-17-047016.hdr.sgml : 20170802 20170802082117 ACCESSION NUMBER: 0001209191-17-047016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170801 FILED AS OF DATE: 20170802 DATE AS OF CHANGE: 20170802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wills Robert James CENTRAL INDEX KEY: 0001634189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 17998443 MAIL ADDRESS: STREET 1: 175 TOYOTA PLAZA, 7TH FLOOR CITY: MEMPHIS STATE: TN ZIP: 38103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-01 0 0001042074 CymaBay Therapeutics, Inc. CBAY 0001634189 Wills Robert James C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BOULEVARD, SUITE 130 NEWARK CA 94560 1 0 0 0 Common Stock 2017-08-01 4 P 0 200 6.829 A 25200 D Common Stock 2017-08-01 4 P 0 300 6.838 A 25500 D Common Stock 2017-08-01 4 P 0 1000 6.839 A 26500 D Common Stock 2017-08-01 4 P 0 3500 6.847 A 30000 D /s/ Sujal Shah, Attorney-in-Fact 2017-08-01